T-DXd With or Without Neratinib for HER2 Positive Breast Cancer With Brain Metastasis

NCT07152782 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

202

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer With Brain Metastasis
HER2-positive Breast Cancer

Interventions

DRUG: Neratinib
DRUG: Trastuzumab Deruxtecan

Sponsor

Fudan University